Phase II Study of Concurrent Continuous Temozolomide (TMZ) and Tamoxifen (TMX) for Recurrent Malignant Astrocytic Gliomas

被引：0
|
作者：
Alexander M. Spence
Richard A. Peterson
Jeffrey D. Scharnhorst
Daniel L. Silbergeld
Robert C. Rostomily
机构：
[1] University of Washington,Department of Neurology, 356465
[2] University of Washington School of Medicine,Departments of Neurology and Neurological Surgery
来源：
Journal of Neuro-Oncology | 2004年 / 70卷
关键词：
anaplastic astrocytoma; glioblastoma multiforme; phase II; Tamoxifen; Temozolomide;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Purpose and background: The aim of this study was to assess the frequency of response and toxicity in adults with recurrent anaplastic astrocytoma (AA) or glioblastoma multiforme (GM) treated with concurrent continuous TMZ and TMX.
引用
收藏
页码：91 / 95
页数：4
相关论文
共 50 条
  • [31] A multicenter phase II study of temozolomide plus disulfiram and copper for recurrent temozolomide-resistant glioblastoma
    Jiayi Huang
    Rekha Chaudhary
    Adam L. Cohen
    Karen Fink
    Samuel Goldlust
    John Boockvar
    Prakash Chinnaiyan
    Leping Wan
    Stephen Marcus
    Jian L. Campian
    Journal of Neuro-Oncology, 2019, 142 : 537 - 544
  • [32] Phase II study of two-weekly temozolomide in patients with high-grade gliomas
    Wong, S
    Rosenthal, MA
    Dowling, A
    Jennens, R
    Woods, AM
    Ashley, D
    Cher, L
    JOURNAL OF CLINICAL NEUROSCIENCE, 2006, 13 (01) : 18 - 22
  • [33] Phase II study of topotecan in patients with recurrent malignant glioma
    Macdonald, D
    Cairncross, G
    Stewart, D
    Forsyth, P
    Sawka, C
    Wainman, N
    Eisenhauer, E
    ANNALS OF ONCOLOGY, 1996, 7 (02) : 205 - 207
  • [34] Phase I study of temozolomide and escalating doses of oral etoposide for adults with recurrent malignant glioma
    Korones, DN
    Benita-Weiss, M
    Coyle, TE
    Mechtler, L
    Bushunow, P
    Evans, B
    Reardon, DA
    Quinn, JA
    Friedman, H
    CANCER, 2003, 97 (08) : 1963 - 1968
  • [35] A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy
    Raizer, Jeffrey J.
    Abrey, Lauren E.
    Lassman, Andrew B.
    Chang, Susan M.
    Lamborn, Kathleen R.
    Kuhn, John G.
    Yung, W. K. Alfred
    Gilbert, Mark R.
    Aldape, Kenneth A.
    Wen, Patrick Y.
    Fine, Howard A.
    Mehta, Minesh
    DeAngelis, Lisa M.
    Lieberman, Frank
    Cloughesy, Timothy F.
    Robins, H. Ian
    Dancey, Janet
    Prados, Michael D.
    NEURO-ONCOLOGY, 2010, 12 (01) : 95 - 103
  • [36] A phase II study of feasibility and toxicity of bevacizumab in combination with temozolomide in patients with recurrent glioblastoma
    J. M. Sepúlveda
    C. Belda-Iniesta
    M. Gil-Gil
    P. Pérez-Segura
    A. Berrocal
    G. Reynés
    O. Gallego
    J. Capellades
    J. M. Ordoñez
    B. La Orden
    C. Balañá
    Clinical and Translational Oncology, 2015, 17 : 743 - 750
  • [37] Infigratinib in Patients with Recurrent Gliomas and FGFR Alterations: A Multicenter Phase II Study
    Lassman, Andrew B.
    Sepulveda-Sanchez, Juan Manuel
    Cloughesy, Timothy F.
    Gil-Gil, Miguel J.
    Puduvalli, Vinay K.
    Raizer, Jeffrey J.
    De Vos, Filip Y. F.
    Wen, Patrick Y.
    Butowski, Nicholas A.
    Clement, Paul M. J.
    Groves, Morris D.
    Belda-Iniesta, Cristobal
    Giglio, Pierre
    Soifer, Harris S.
    Rowsey, Steven
    Xu, Cindy
    Avogadri, Francesca
    Wei, Ge
    Moran, Susan
    Roth, Patrick
    CLINICAL CANCER RESEARCH, 2022, 28 (11) : 2270 - 2277
  • [38] Low-dose fotemustine for recurrent malignant glioma: a multicenter phase II study
    Fabi, Alessandra
    Metro, Giulio
    Vidiri, Antonello
    Lanzetta, Gaetano
    Carosi, Mariantonia
    Telera, Stefano
    Maschio, Marta
    Russillo, Michelangelo
    Sperduti, Isabella
    Carapella, Carmine M.
    Cognetti, Francesco
    Pace, Andrea
    JOURNAL OF NEURO-ONCOLOGY, 2010, 100 (02) : 209 - 215
  • [39] Phase II multicentre study of temozolomide in combination with interferon alpha-2b in metastatic malignant melanoma
    Garcia, Margarita
    del Muro, Xavier Garcia
    Tres, Alejandro
    Crespo, Carmen
    Valladares, Manuel
    Lopez, Juan Jose
    Rifa, Julio
    Perez, Xavier
    Filipovich, Elena
    Germa-Lluch, Josep Ramon
    MELANOMA RESEARCH, 2006, 16 (04) : 365 - 370
  • [40] A phase II study of feasibility and toxicity of bevacizumab in combination with temozolomide in patients with recurrent glioblastoma
    Sepulveda, J. M.
    Belda-Iniesta, C.
    Gil-Gil, M.
    Perez-Segura, P.
    Berrocal, A.
    Reynes, G.
    Gallego, O.
    Capellades, J.
    Ordonez, J. M.
    La Orden, B.
    Balana, C.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2015, 17 (09) : 743 - 750
12345